News | June 30, 2022
Pfizer and BioNTech inks new agreement with US Government to provide additional doses of COVID-19 vaccine
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses